Skip to content

An Interventional Study Comparing the Effectiveness of Manjishtadi Taila and Manjishtadi Cream in the Management of hyperpigmentation (Melasma)

A Comparative Randomized Clinical Trial of Manjishtadi Taila and Manjishtadi Cream in the Management of Vyanga with Special Reference to Melasma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079618
Enrollment
30
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Sponsors

National Institute of Ayurveda, Deemed to be University, Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting clinical features of Vyanga - sudden onset of painless, circular, thin, blackish patches on face.

Exclusion criteria

Exclusion criteria: Patients with known case of Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leukoderma and Leprosy. Patients with known case of common systemic diseases like T.B. Diabetes, AIDS and Chickenpox.

Design outcomes

Primary

MeasureTime frame
Change in severity of pigmentation measured as per the assessment criteria - size, color, number of patches, associated symptoms like itching and burning sensation, mMASI score at baseline and after treatment. Timepoint: 2 months

Secondary

MeasureTime frame
Adverse Events-Monitoring and documenting any side effects or complications arising from treatmentTimepoint: 2 months

Countries

India

Contacts

Public ContactDr Jagriti Sharma

National Institute of Ayurveda, Deemed to be University, Jaipur

Vd.krutika@gmail.com9408648068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026